We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Symbotic Stock Surges 134.5% YTD: Should You Buy Now or Wait?
Read MoreHide Full Article
Key Takeaways
SYM shares surged 134.5% YTD, outperforming industry peers on AI momentum and technical strength.
Backlog of $22.4B with improved deployment times set to drive future revenue and margin gains.
High valuation, earnings volatility, and reliance on Walmart remain key investor concerns.
Driven by the artificial intelligence or AI frenzy, shares of Symbotic (SYM - Free Report) have performed exceptionally well so far this year, soaring 134.5%. On a year-to-date basis, SYM shares have performed much better than its industry and industry peers, Coherent Corp. (COHR - Free Report) and MediaAlpha (MAX - Free Report) . Coherent Corp. gained 21.9%, while MediaAlpha declined 6.8% in the same period.
Image Source: Zacks Investment Research
Given SYM’s impressive rally, investors might wonder if the opportunity to add this high-flying stock to their portfolio has passed or still exists. To answer the question, let’s delve deep as far as SYM stock is concerned.
Factors Working in favor of SYM
Technical indicators suggest continued strong performance for SYM. The stock trades above its 50-day moving average, signaling robust upward momentum and price stability. This technical strength underscores positive market sentiment and confidence in SYM’s prospects.
50-Day Moving Average Data of SYM Stock
Image Source: Zacks Investment Research
Symbiotic’s high backlog positions it to generate substantial revenues in the foreseeable future. We are optimistic about its margin expansion, driven by increased system deployment. Furthermore, a high free cash flow and a favorable current ratio hint at high liquidity, attracting investor attention.
In the third quarter of fiscal 2025, results of which were released on Aug. 6, the company had $22.4 billion in backlog. Management stated that the company expects to recognize nearly 11% of its remaining performance obligations as revenues in the next 12 months, 56% of its remaining performance obligations as revenues in the following 13-60 months, and the rest thereafter.
Revenues increased 26% year over year. We expect the top line to be driven, going forward as well, by converting this sizable backlog. For the fourth quarter of fiscal 2025, Symbotic expects revenues in the $590-$610 million range, and adjusted EBITDA in the $45-$49 million band. The improvement in deployment efficiency is likely to fuel revenues and margins going forward as well.
Apart from boosting revenues, faster deployment times imply that Symbotic is executing installations more smoothly compared to its historical averages, suggesting that labor hours per project are decreasing. This also suggests that rework incidents are declining
Headwinds that cannot be ignored
SYM’s earnings surprise history is not impressive. In the four trailing quarters, it surpassed the Zacks Consensus Estimate twice and missed in the other two, with an average negative surprise of 78.3%.
SYM stock is not so cheap, as its Value Score of F suggests a stretched valuation at this moment.
In terms of the forward price-to-sales ratio, SYM is trading at 12.09X, higher than its industry and fellow industry players Coherent Corp and MediaAlpha. Coherent Corp. and MediaAlpha have a Value Score of D and A, respectively.
Image Source: Zacks Investment Research
SYM’s partnership with Walmart (WMT - Free Report) has been very profitable, accounting for a significant portion of the former’s revenues. Walmart is the largest customer of SYM. While we do not anticipate any threat soon, since Walmart has invested in Symbiotic, investors should be cautious about customer concentration risks. Additionally, Symbiotic currently does not pay dividends and has no plans to do so, which weakens its appeal for income-focused investors.
Final Verdict
Symbiotic’s high backlog positions it to generate substantial revenues in the foreseeable future. We are optimistic about its margin expansion, driven by increased system deployment. Despite these tailwinds, challenges like high valuation and customer concentration risks make us believe that it is still not an opportune time to buy this Zacks Rank #3 (Hold) stock.
Investors should monitor the company’s developments closely for an appropriate entry point. For those who already own the stock, it will be prudent to stay invested.
Image: Bigstock
Symbotic Stock Surges 134.5% YTD: Should You Buy Now or Wait?
Key Takeaways
Driven by the artificial intelligence or AI frenzy, shares of Symbotic (SYM - Free Report) have performed exceptionally well so far this year, soaring 134.5%. On a year-to-date basis, SYM shares have performed much better than its industry and industry peers, Coherent Corp. (COHR - Free Report) and MediaAlpha (MAX - Free Report) . Coherent Corp. gained 21.9%, while MediaAlpha declined 6.8% in the same period.
Given SYM’s impressive rally, investors might wonder if the opportunity to add this high-flying stock to their portfolio has passed or still exists. To answer the question, let’s delve deep as far as SYM stock is concerned.
Factors Working in favor of SYM
Technical indicators suggest continued strong performance for SYM. The stock trades above its 50-day moving average, signaling robust upward momentum and price stability. This technical strength underscores positive market sentiment and confidence in SYM’s prospects.
50-Day Moving Average Data of SYM Stock
Symbiotic’s high backlog positions it to generate substantial revenues in the foreseeable future. We are optimistic about its margin expansion, driven by increased system deployment. Furthermore, a high free cash flow and a favorable current ratio hint at high liquidity, attracting investor attention.
In the third quarter of fiscal 2025, results of which were released on Aug. 6, the company had $22.4 billion in backlog. Management stated that the company expects to recognize nearly 11% of its remaining performance obligations as revenues in the next 12 months, 56% of its remaining performance obligations as revenues in the following 13-60 months, and the rest thereafter.
Revenues increased 26% year over year. We expect the top line to be driven, going forward as well, by converting this sizable backlog. For the fourth quarter of fiscal 2025, Symbotic expects revenues in the $590-$610 million range, and adjusted EBITDA in the $45-$49 million band. The improvement in deployment efficiency is likely to fuel revenues and margins going forward as well.
Apart from boosting revenues, faster deployment times imply that Symbotic is executing installations more smoothly compared to its historical averages, suggesting that labor hours per project are decreasing. This also suggests that rework incidents are declining
Headwinds that cannot be ignored
SYM’s earnings surprise history is not impressive. In the four trailing quarters, it surpassed the Zacks Consensus Estimate twice and missed in the other two, with an average negative surprise of 78.3%.
Symbotic Price and EPS Surprise
Symbotic price-eps-surprise | Symbotic Quote
SYM stock is not so cheap, as its Value Score of F suggests a stretched valuation at this moment.
In terms of the forward price-to-sales ratio, SYM is trading at 12.09X, higher than its industry and fellow industry players Coherent Corp and MediaAlpha. Coherent Corp. and MediaAlpha have a Value Score of D and A, respectively.
Image Source: Zacks Investment Research
SYM’s partnership with Walmart (WMT - Free Report) has been very profitable, accounting for a significant portion of the former’s revenues. Walmart is the largest customer of SYM. While we do not anticipate any threat soon, since Walmart has invested in Symbiotic, investors should be cautious about customer concentration risks. Additionally, Symbiotic currently does not pay dividends and has no plans to do so, which weakens its appeal for income-focused investors.
Final Verdict
Symbiotic’s high backlog positions it to generate substantial revenues in the foreseeable future. We are optimistic about its margin expansion, driven by increased system deployment. Despite these tailwinds, challenges like high valuation and customer concentration risks make us believe that it is still not an opportune time to buy this Zacks Rank #3 (Hold) stock.
Investors should monitor the company’s developments closely for an appropriate entry point. For those who already own the stock, it will be prudent to stay invested.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.